Next Article in Journal
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018
Previous Article in Journal
Implementing A One-Day Testing Model Improves Timeliness of Workup for Patients with Lung Cancer
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clinical Practice Guideline for Image-Guided Multimode Tumour Ablation Therapy in Hepatic Malignant Tumours

1
Department of Interventional Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Rd, Shanghai 200032, China
2
Department of Oncology, Affiliated Shanghai 6th People’s Hospital, Shanghai Jiaotong University, Shanghai, China
3
Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China
4
Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
5
Department of Interventional Radiology, Changhai Hospital, Naval Medical University, Shanghai, China
*
Authors to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(5), 658-664; https://0-doi-org.brum.beds.ac.uk/10.3747/co.26.5423
Submission received: 10 July 2019 / Revised: 12 August 2019 / Accepted: 7 September 2019 / Published: 1 October 2019

Abstract

Multimode tumour ablation therapy is a treatment method that combines cryoablation with radiofrequency ablation, guided by medical imaging technology and based on precise planning, targeting, monitoring, and control of the thermal energy delivered, with the aim of achieving a whole-body antitumour immune response to malignant tumours. To develop standardized criteria for the application of multimode tumour ablation therapy to malignant hepatic tumours, to facilitate actualization of the criteria in various hospitals, and to ensure therapeutic efficacy and safety, the Society of Interventional Therapy of the Chinese Anti-Cancer Association and the Solid Tumor Theranostics Committee of the Shanghai Anti-Cancer Association assembled experts who specialize in oncology to discuss this treatment method and to arrive at a clinical practice consensus guideline for the indications, contraindications, and techniques of multimode tumour ablation therapy for malignant hepatic tumours.
Keywords: Cryosurgery; cryoablation; radiofrequency ablation; liver neoplasms; consensus statements Cryosurgery; cryoablation; radiofrequency ablation; liver neoplasms; consensus statements

Share and Cite

MDPI and ACS Style

Wang, G.-Z.; He, X.H.; Wang, Y.; Xu, L.C.; Huang, H.Z.; Wang, Y.H.; Shen, Z.; Qu, X.D.; Ding, X.Y.; Yang, J.J.; et al. Clinical Practice Guideline for Image-Guided Multimode Tumour Ablation Therapy in Hepatic Malignant Tumours. Curr. Oncol. 2019, 26, 658-664. https://0-doi-org.brum.beds.ac.uk/10.3747/co.26.5423

AMA Style

Wang G-Z, He XH, Wang Y, Xu LC, Huang HZ, Wang YH, Shen Z, Qu XD, Ding XY, Yang JJ, et al. Clinical Practice Guideline for Image-Guided Multimode Tumour Ablation Therapy in Hepatic Malignant Tumours. Current Oncology. 2019; 26(5):658-664. https://0-doi-org.brum.beds.ac.uk/10.3747/co.26.5423

Chicago/Turabian Style

Wang, Guang-Zhi, X. H. He, Y. Wang, L. C. Xu, H. Z. Huang, Y. H. Wang, Z. Shen, X. D. Qu, X. Y. Ding, J. J. Yang, and et al. 2019. "Clinical Practice Guideline for Image-Guided Multimode Tumour Ablation Therapy in Hepatic Malignant Tumours" Current Oncology 26, no. 5: 658-664. https://0-doi-org.brum.beds.ac.uk/10.3747/co.26.5423

Article Metrics

Back to TopTop